FBIO is expected to report earnings to fall 9.52% to -18 cents per share on August 17
Q2'26
Est.
$-0.19
Q4'25
Missed
by $0.24
Q3'25
Beat
by $0.12
Q2'25
Beat
by $0.38
Q1'25
Missed
by $0.36
The last earnings report on March 31 showed earnings per share of -20 cents, missing the estimate of 2 cents. With 505.38K shares outstanding, the current market capitalization sits at 109.62M.
A.I. Advisor
published General Information
General Information
a developer of novel immunotherapy biologic agents
A.I.dvisor indicates that over the last year, FBIO has been loosely correlated with FBIOP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIO jumps, then FBIOP could also see price increases.
Aroon Indicator for FBIO shows an upward move is likely
FBIO's Aroon Indicator triggered a bullish signal on July 06, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 113 similar instances where the Aroon Indicator showed a similar pattern. In of the 113 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 09, 2026. You may want to consider a long position or call options on FBIO as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for FBIO just turned positive on July 09, 2026. Looking at past instances where FBIO's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FBIO advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBIO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
FBIO broke above its upper Bollinger Band on July 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.676) is normal, around the industry mean (22.746). P/E Ratio (1.022) is within average values for comparable stocks, (37.261). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.488). FBIO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (1.541) is also within normal values, averaging (432.117).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FBIO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FBIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
